National Jewish Health and Saint Joseph Hospital Launch a Robotic Bronchoscopy Program

January 15, 2021

National Jewish Health* and Saint Joseph Hospital** are among the first hospitals in the Rocky Mountain region to have minimally invasive robotic technology that enables physicians to obtain tissue samples from deep within the lung where 70 percent of nodules reside.

“It’s exciting to be able to offer patients with lung nodules an alternative to surgical biopsy,” said Ellen Volker, MD, MSPH, Director of Interventional Pulmonology at National Jewish Health and interventional pulmonologist at Saint Joseph Hospital. “Robotic bronchoscopy allows us to reach more types of lung nodules throughout the entirety of the lung, in one minimally invasive outpatient procedure.”

Dr. Volker explained that National Jewish Health and Saint Joseph Hospital are among the first in the U.S. to combine cone-beam CT technology with robotic bronchoscopy technology. Cone-beam CT allows the doctor to be even more accurate and precise while performing the lung biopsy.

“Our success rate in reaching and successfully obtaining a tissue sample from difficult-to-reach areas of the lung with robotic bronchoscopy and cone-beam CT is greater than 90 percent. Older technologies like electromagnetic navigation bronchoscopy had a success rate of only around 50 percent,” explained Dr. Volker. “This new technology is very good news for lung nodule patients, especially those who may have lung cancer.”

Lung cancer continues to be the leading cause of cancer-related death in men and women. Early detection of lung cancer is one of the best ways to have a successful outcome, but early-stage lung cancers tend to be small and difficult to reach. Robotic bronchoscopy allows physicians to diagnose and stage lung cancer in one minimally invasive procedure, rather than multiple procedures.

“As with all cancers, the sooner we can diagnose and stage lung cancer, the better the outcomes for the patients,” said Dr. Volker.

*National Jewish Health is the leading respiratory hospital in the nation. Founded 122 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune, and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit the media resources page.

**SCL Saint Joseph Hospital founded in Denver in 1873 by the Sisters of Charity Leavenworth was the first private hospital in Colorado. Today it is recognized as one of the top hospitals in the nation and largest private teaching hospital in Denver. Specializing in a variety of areas including advanced heart care, pregnancy and childbirth and cancer treatment, Saint Joseph Hospital continues to offer the high-quality, affordable health care that has served Denver for more than 140 years. By working closely with top physicians, Kaiser Permanente and National Jewish Health, the leading respiratory hospital in the nation, Saint Joe’s is able to provide some of the best inpatient and outpatient care in Colorado. Saint Joseph Hospital is part of SCL Health.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version